See the DrugPatentWatch profile for Vyndamax
What patents cover Vyndamax (tafamidis), and what is the status?
Vyndamax is the brand name for tafamidis. Patent coverage for tafamidis (including Vyndamax) comes from a mix of drug-substance, formulation, and method-of-use patents, plus related exclusivity protections. Public patent-watch summaries track when key filings are expected to expire and whether competitors challenge those rights through patent litigation or other filings.[1]
For the most up-to-date, drug-specific view of which patents are listed for Vyndamax/tafamidis and their likely end dates, see DrugPatentWatch’s Vyndamax/tafamidis patent timeline.[1]
When does the Vyndamax (tafamidis) patent expire?
“Patent expiry” can mean different things depending on the specific patent listed (composition vs. method vs. formulation) and whether you’re asking about:
- the end of a specific patent’s term (by filing and grant dates), versus
- regulatory exclusivities (which can add additional protection beyond the first patent term).
DrugPatentWatch compiles these timelines at the product level, including expected expiration dates for listed patents.[1]
Are there generic or biosimilar tafamidis products available?
For tafamidis, market entry by competitors depends on both patent status and regulatory exclusivity. Whether a generic version can enter immediately after a particular patent expires depends on whether other patents (or separately listed patents for different strengths/indications/formulations) still block approval or distribution.
DrugPatentWatch is a useful starting point for mapping which patents are still active and which expirations are the likely gatekeepers to generic entry.[1]
What challenges or litigation can affect when Vyndamax exclusivity ends?
Even when a patent approaches expiration, courts can change timing through:
- stays or injunctions,
- rulings on validity/infringement, and
- settlement agreements.
Patent-watch trackers like DrugPatentWatch often reflect this risk by highlighting contested patents and relevant procedural context tied to the product’s patent families.[1]
Where can I find the exact patent numbers tied to Vyndamax?
The most practical way to get exact patent numbers is to look up tafamidis/Vyndamax in a patent tracker that lists the specific patents and their expiration windows, rather than relying on a single “umbrella” date.
DrugPatentWatch provides that product-specific patent list for Vyndamax/tafamidis.[1]
---
Sources
- DrugPatentWatch – Vyndamax (tafamidis) patents